Migrasome Therapeutic
Latest round
- Angel
Last raised
- Jul 2023
Total raised
- $14M
Investors
- 5
About Migrasome Therapeutic
Based in Beijing, China, and established in 2022, Migrasome Therapeutic is a biotechnology company that focuses on the R&D of new drugs. The company was established by professor Li Yu, at Life Sciences College, Tsinghua University. In 2012, the professor Li Yu team discovered and named a new organelle, the migrator. In 2015, professor Li Yu published a paper on the Cell Research journal, and reporting on the migrator. Migrasome Therapeutic developed engineered drug delivery platforms, migrator-related innovative drugs and diagnostic products. The migrator is membranous organelles produced during cell migration, and natural signal delivery systems in the body. The migrator can be used in the fields of drug delivery, and tumour immunity.
Who invested in Migrasome Therapeutic
5 investors across 1 round
See all investors in Migrasome Therapeutic
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Jul 25, 2023
Amount
$14M
Investors
Questions about Migrasome Therapeutic
Who invested in Migrasome Therapeutic?
Migrasome Therapeutic has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Migrasome Therapeutic raised?
Migrasome Therapeutic has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Migrasome Therapeutic last raise money?
Migrasome Therapeutic's most recent round on record is a Angel, in Jul 2023.
What does Migrasome Therapeutic do?
Based in Beijing, China, and established in 2022, Migrasome Therapeutic is a biotechnology company that focuses on the R&D of new drugs.
Where is Migrasome Therapeutic headquartered?
Migrasome Therapeutic is headquartered in Beijing, China.
Which VCs invest in companies like Migrasome Therapeutic?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Migrasome Therapeutic's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like Migrasome Therapeutic? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.